AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,178,000 | +1588.9% | 151,117 | +907.4% | 2.65% | +904.5% |
| Q4 2018 | $425,000 | -92.8% | 15,000 | -88.0% | 0.26% | -90.6% |
| Q3 2018 | $5,908,000 | +492.0% | 125,179 | +747.0% | 2.81% | +633.2% |
| Q2 2018 | $998,000 | +24.4% | 14,779 | 0.0% | 0.38% | +22.4% |
| Q1 2018 | $802,000 | -9.2% | 14,779 | 0.0% | 0.31% | +0.6% |
| Q4 2017 | $883,000 | +23.0% | 14,779 | 0.0% | 0.31% | +11.5% |
| Q3 2017 | $718,000 | -85.4% | 14,779 | -84.2% | 0.28% | -85.1% |
| Q2 2017 | $4,926,000 | +624.4% | 93,822 | +525.5% | 1.87% | +620.0% |
| Q1 2017 | $680,000 | -86.9% | 15,000 | -89.1% | 0.26% | -88.9% |
| Q4 2016 | $5,210,000 | – | 138,000 | – | 2.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |